Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy

Overview of attention for article published in Frontiers in Pain Research, August 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,758 followers.

RT @FrontPain: New Research: Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy https://t.co/7PSXKpkIic #pain

New Research: Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy https://t.co/7PSXKpkIic #pain

We cannot leave pregnant women with #ChronicMigraine behind. More research needs to be done, but Botox is one option we should consider for this group: https://t.co/deo0qNA2V0 #pregnancy #migraine #headachemedicine

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.